0001104659-22-012937.txt : 20220207 0001104659-22-012937.hdr.sgml : 20220207 20220207205903 ACCESSION NUMBER: 0001104659-22-012937 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220207 FILED AS OF DATE: 20220207 DATE AS OF CHANGE: 20220207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Murphy-Chutorian Douglas CENTRAL INDEX KEY: 0001594342 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36305 FILM NUMBER: 22599084 MAIL ADDRESS: STREET 1: C/O SEMLER SCIENTIFIC, INC. STREET 2: 911 BERN COURT, SUITE 110 CITY: SAN JOSE STATE: CA ZIP: 95112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Semler Scientific, Inc. CENTRAL INDEX KEY: 0001554859 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 261367393 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2340-2348 WALSH AVENUE, SUITE 2344 CITY: SANTA CLARA STATE: CA ZIP: 95051 BUSINESS PHONE: 408-627-4557 MAIL ADDRESS: STREET 1: 2340-2348 WALSH AVENUE, SUITE 2344 CITY: SANTA CLARA STATE: CA ZIP: 95051 4 1 tm225807d1_4.xml OWNERSHIP DOCUMENT X0306 4 2022-02-07 0 0001554859 Semler Scientific, Inc. SMLR 0001594342 Murphy-Chutorian Douglas C/O SEMLER SCIENTIFIC, INC. 2340-2348 WALSH AVENUE, SUITE 2344 SANTA CLARA CA 95051 1 1 1 0 Chief Executive Officer Common Stock 2022-02-07 4 M 0 2000 2.10 A 2000 D Common Stock 2022-02-07 4 S 0 647 77.6798 D 1353 D Common Stock 2022-02-07 4 S 0 743 78.4728 D 610 D Common Stock 2022-02-07 4 S 0 510 79.8784 D 100 D Common Stock 2022-02-07 4 S 0 100 81.4850 D 0 D Stock Option (right to buy) 2.10 2022-02-07 4 M 0 2000 0 D 2024-11-08 Common Stock 2000 77000 D Shares sold pursuant to a 10b5-1 trading plan adopted by the reporting person on December 7, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.14 to $78.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3 to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.19 to $79.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.60 to $80.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4. The shares underlying the option are fully vested and immediately exercisable. /s/ Daniel E. Conger, Attorney-in-fact 2022-02-07